Literature DB >> 33069812

Auditory function analysis in immunodeficient STAT1 knock-out mice: Considerations for viral infection models.

Tomoharu Suzuki1, Junki Maruyama2, Rebecca Cook1, Shinji Urata1, Slobodan Paessler2, Tomoko Makishima3.   

Abstract

The STAT1 knock-out (KO) mouse is a frequently used transgenic immunodeficient strain to model human viral and bacterial diseases. The Lassa fever model was established in the STAT1 KO mice mimicking phenotypes seen in human patients including deafness in survivors. This model develops hearing loss at high prevalence and is a valuable tool to investigate viral infection-induced hearing loss. However, Lassa virus is a highly contagious and regulated agent requiring the unique logistics of the biosafety level 4 posing limitations for experimental work. Therefore, we did a detailed auditory analysis of the STAT1 KO mice to assess baseline auditory function in preparation for further auditory behavioral studies. Auditory brainstem response and distortion product otoacoustic emission tests were performed on males and females of the STAT1 KO mice and was compared to 129S6/SvEv wild type (WT) mice. The male WT mice had the best auditory performance and the female WT mice had the worst hearing performance. The male and female STAT1 KO mice had similar auditory performance to each other, which was intermediate between WT males and females. We conclude that both male and female STAT1 KO mice are suitable for studying viral infection-induced hearing loss.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABR; DPOAE; Hearing loss; Lassa fever; STAT1

Mesh:

Substances:

Year:  2020        PMID: 33069812      PMCID: PMC7708419          DOI: 10.1016/j.neulet.2020.135427

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Deafness associated with Lassa fever.

Authors:  L P Rybak
Journal:  JAMA       Date:  1990 Oct 24-31       Impact factor: 56.272

2.  A Chromosome 17 Locus Engenders Frequency-Specific Non-Progressive Hearing Loss that Contributes to Age-Related Hearing Loss in Mice.

Authors:  Braulio Peguero; Bruce L Tempel
Journal:  J Assoc Res Otolaryngol       Date:  2015-05-05

3.  Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus.

Authors:  Nadezhda E Yun; Alexey V Seregin; David H Walker; Vsevolod L Popov; Aida G Walker; Jeanon N Smith; Milagros Miller; Juan C de la Torre; Jennifer K Smith; Viktoriya Borisevich; Joseph N Fair; Nadia Wauquier; Donald S Grant; Bayon Bockarie; Dennis Bente; Slobodan Paessler
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

4.  Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder.

Authors:  Tomoko Makishima; Clara I Rodriguez; Nahid G Robertson; Cynthia C Morton; Colin L Stewart; Andrew J Griffith
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

5.  The effect of isoflurane, halothane and pentobarbital on noise-induced hearing loss in mice.

Authors:  Jong Woo Chung; Joong Ho Ahn; Jong Yang Kim; Hyun Jung Lee; Hun Hee Kang; Yoon Kyung Lee; Joung Uk Kim; Seung-Woo Koo
Journal:  Anesth Analg       Date:  2007-06       Impact factor: 5.108

6.  Inner ear dysfunction in caspase-3 deficient mice.

Authors:  Tomoko Makishima; Lara Hochman; Patrick Armstrong; Eric Rosenberger; Ryan Ridley; Minna Woo; Adrian Perachio; Scott Wood
Journal:  BMC Neurosci       Date:  2011-10-12       Impact factor: 3.288

7.  Development of a model for marburgvirus based on severe-combined immunodeficiency mice.

Authors:  Kelly L Warfield; Derron A Alves; Steven B Bradfute; Daniel K Reed; Sean VanTongeren; Warren V Kalina; Gene G Olinger; Sina Bavari
Journal:  Virol J       Date:  2007-10-25       Impact factor: 4.099

8.  Lassa Fever in Pregnancy: Report of 2 Cases Seen at the University College Hospital, Ibadan.

Authors:  O O Bello; O R Akinajo; K H Odubamowo; T A O Oluwasola
Journal:  Case Rep Obstet Gynecol       Date:  2016-03-09

9.  Caseload and Case Fatality of Lassa Fever in Nigeria, 2001-2018: A Specialist Center's Experience and Its Implications.

Authors:  George O Akpede; Danny A Asogun; Sylvanus A Okogbenin; Simeon O Dawodu; Mojeed O Momoh; Andrew E Dongo; Chiedozie Ike; Ekaete Tobin; Nosa Akpede; Ephraim Ogbaini-Emovon; Adetunji E Adewale; Oboratare Ochei; Frank Onyeke; Martha O Okonofua; Rebecca O Atafo; Ikponmwosa Odia; Donatus I Adomeh; George Odigie; Caroline Ogbeifun; Ekene Muebonam; Chikwe Ihekweazu; Michael Ramharter; Andres Colubri; Pardis C Sarbeti; Christian T Happi; Stephan Günther; Dennis E Agbonlahor
Journal:  Front Public Health       Date:  2019-06-25

10.  Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review.

Authors:  Noah Fongwen Takah; Polina Brangel; Priyanka Shrestha; Rosanna Peeling
Journal:  BMC Infect Dis       Date:  2019-07-19       Impact factor: 3.090

View more
  1 in total

1.  CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.

Authors:  Junki Maruyama; Rachel A Reyna; Megumi Kishimoto-Urata; Shinji Urata; John T Manning; Nantian Harsell; Rebecca Cook; Cheng Huang; Janko Nikolich-Zugich; Tomoko Makishima; Slobodan Paessler
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.